Home › Esophageal Adenocarcinoma › Illinois › Waukegan
Esophageal Adenocarcinoma clinical trials in Waukegan, IL
4 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Waukegan (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
- and 1 more
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- City of Hope Cancer Center-Chicago, Zion · 6 mi away
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Zion · 6 mi away
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- St. Louis, MO9 studies
- Baldwin Park, CA9 studies
- Rochester, MN9 studies
- Jacksonville, FL9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Waukegan
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer16 studies
- Breast Cancer12 studies
- Ulcerative Colitis7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Ovarian Cancer6 studies
- Metastatic Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Melanoma5 studies
- Acute Myeloid Leukemia5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.